MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    The efficacy of thalamic and pallidal deep brain stimulation rescue leads in dystonic tremor depends on the affected body region – a case series

    S. Paschen, J. Becktepe, M. Hobert, K. Zeuner, A. Helmers, D. Berg, G. Deuschl (Kiel, Germany)

    Objective: We aim to investigate whether the body region affected by dystonic tremor and dystonia is important for target selection. Background: For the treatment of…
  • 2023 International Congress

    Motor control of finger individuation and strength in patients with Parkinson’s disease and Spinocerebellar Ataxia type 12

    S. Majumdar, A. Bayen, S. Choudhury, P. Basu, M. Baker, S. Baker, H. Kumar (Kolkata, India)

    Objective: Compare finger individuation (FI) and maximum finger strength in healthy control, patients with Parkinson’s Disease (PD) and Spinocerebellar ataxia type12 (SCA12). We also examined…
  • 2023 International Congress

    Social cognition in cervical dystonia: an fMRI study

    S. Rafee, D. Kelly, C. Fearon, M. Hutchinson, R. Reilly (Dublin, Ireland)

    Objective: Study functional changes within a network that mediates recognition of facial expressions in patients with cervical dystonia by MRI. Background: Cervical dystonia (CD) is…
  • 2023 International Congress

    An Exploration of the Psychosocial Impact of Receiving Treatment at a Sialorrhea Clinic for People with Parkinson’s Disease

    M. Vazirian Zadeh, J. Adenwalla, C. Marquis, B. Mohamed, C. Thomas, R. Lewis-Morton (Penarth, United Kingdom)

    Objective: To explore the psychosocial impact (impact on quality of life, self-compassion, self-esteem & shame) of receiving treatment for sialorrhea in people with Parkinson’s. Background:…
  • 2023 International Congress

    Widespread Synuclein pathology in hyposmics precedes dopamine transporter deficit in PARS

    K. Marek, D. Russell, L. Concha, C. Caspell-Garcia, E. Brown, M. Brumm, C. Choi, M. Stern, D. Jennings, C. Soto, A. Siderowf (New Haven, USA)

    Objective: The Parkinson Associated Risk syndrome (PARS) study is designed to identify a Parkinson disease (PD) biomarker/clinical marker derived cohort enriched to develop typical symptoms…
  • 2023 International Congress

    Diabetes impact on nigrostriatal vulnerability in Parkinson’s Disease

    A. Galli, A. Pilotto, C. Zatti, C. Tirloni, A. Lupini, B. Paghera, A. Padovani (Brescia, Italy)

    Objective: aim of the study was to investigate whether diabetes mellitus influences nigrostriatal dopaminergic vulnerability in drug-naïve patients with early-stage Parkinson’s Disease (PD). Background: recently,…
  • 2023 International Congress

    Subjective cognitive decline and Frailty in an Asian cohort of patients with Parkinson’s Disease

    P. Venugopalan Menon, K. Gai Fui, E. Elda Kamaruddin, L. Sun, CH. Tan, P. Chong, S. Kumar Seetharaman (Singapore, Singapore)

    Objective: To assess the prevalence of subjective cognitive decline (SCD) and to look for its association with frailty in an Asian cohort of patients with…
  • 2023 International Congress

    Burden and management of tardive dyskinesia (TD): a cross-sectional international survey study to assess the perceptions and experiences of patients with TD

    R. Ribalov, A. Yaari, A. Peyser Levin, A. Yang, D. Horchi, E. Berjonneau, P. Le Calvé, M. Tian, S. Reshef, S. Reed (Tel-Aviv-Yafo, Israel)

    Objective: To assess patient perceptions of and experiences with TD and its impact on their daily functioning and quality of life (QoL). Background: There is…
  • 2023 International Congress

    Utility of neurophysiological markers in clinical management of subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkinson’s disease (PD)-a case report.

    K. Markopoulou, P. Warnke (Evanston, USA)

    Objective: Use local field potentials (LFP) to inform longitudinal clinical decision making. Background: Genetic status, clinical and stimulation parameters affect outcomes in PD STN DBS.…
  • 2023 International Congress

    Clinical-based diagnosis and self-reported Parkinson’s disease in a population-based sample in southern Brazil

    G. Pereira, N. Soares, G. Marconi, C. Sangali, I. Pasuch, C. Bertocchi, N. Bruscato, J. Senger, A. Schumacher-Schuh, C. Rieder (Porto Alegre, Brazil)

    Objective: To report the frequency of self-reported PD and the diagnostic evaluation performed by clinical neurologists in a population-based cohort from south Brazil. Background: It…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley